Literature DB >> 122891

Managing the complications of plasma cell myeloma.

H J Cohen, R W Rundles.   

Abstract

Management of some diverse complications of plasma cell myeloma is reviewed with respect to prevention when possible and prompt treatment when necessary. A series of 102 patients from the Duke University Medical Center was surveyed to ascertain the approximate frequency with which renal failure, hypercalcemia, infection, hyperviscosity syndrome, and neurologic disorders occur. Selected patient studies and additional data from the literature emphasize aspects of these complications amenable to therapy aside from that directed at plasma cell growth.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 122891

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

Review 1.  Myeloma light chain cast nephropathy, a review.

Authors:  Insara Jaffer Sathick; Maria Eleni Drosou; Nelson Leung
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

2.  T-cell imbalances in patients with multiple myeloma: an analysis by monoclonal antibodies.

Authors:  C D Platsoucas; H J Hansen; J R Redman; S Berenson; B J Lee; B D Clarkson
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

3.  The cost of chronic dialysis in multiple myeloma.

Authors:  R A Coward
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

4.  Treatment of acute renal failure due to myeloma kidney.

Authors:  R A Bear; E H Cole; A Lang; M Johnson
Journal:  Can Med Assoc J       Date:  1980-10-18       Impact factor: 8.262

5.  Serum antibodies against common antigens of bacterial lipopolysaccharides in healthy adults and in patients with multiple myeloma.

Authors:  C Stoll; I Schedel; D Peest
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.